Overview

Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

Status:
Completed

Trial end date:
2004-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether treatment with rosuvastatin following atorvastatin or simvastatin treatment will improve health outcomes for patients at high risk of Coronary heart disease compared to atorvastatin and simvastatin alone.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Atorvastatin
Atorvastatin Calcium
Hypolipidemic Agents
Rosuvastatin Calcium
Simvastatin